Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 9/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5847865 | 0.90 | CHRM1 (0.41) | CHRM1KCNH2CHRM4CHRM5 | |
| SCHEMBL5849383 | 0.82 | CHRM1 (0.42) | CHRM1CHRM4CHRM5ALDH1A1 | |
| SCHEMBL8261001 | 0.81 | SMN1; SMN2 (0.40) | LMNAPOLBSMN1; SMN2CHRM1CHRM4 | |
| SCHEMBL17061265 | 0.80 | CHRM1 (0.52) | CHRM1KCNH2ALDH1A1 | |
| SCHEMBL7055895 | 0.79 | CHRM1 (0.41) | CHRM1KCNH2CHRM4CHRM5 | |
| SCHEMBL17061337 | 0.77 | AGTR2 (0.52) | SMN1; SMN2CHRM1KCNH2CHRM4CHRM5 | |
| SCHEMBL8259202 | 0.76 | LMNA (0.43) | LMNAPOLBSMN1; SMN2CHRM1CHRM4 | |
| SCHEMBL30068327 | 0.75 | LMNA (0.42) | LMNAPOLBSMN1; SMN2CHRM1CHRM4 | |
| SCHEMBL30532513 | 0.75 | LMNA (0.42) | LMNAPOLBSMN1; SMN2CHRM1CHRM4 | |
| SCHEMBL12086277 | 0.75 | LMNA (0.42) | LMNAPOLBSMN1; SMN2CHRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017184549-A1 | PYRROLOPYRIDINE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | INNOV17 LLC (US) | 2017-10-26 | — | — | WO | disclosed |
| EP-3172197-A1 | BENZIMIDAZOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | Innov17 LLC (US) | 2017-05-31 | — | — | EP | disclosed |
| EP-3172196-A1 | AZAINDOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | Innov17 LLC (US) | 2017-05-31 | — | — | EP | disclosed |
| EP-3172195-A1 | SULFONAMIDE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | Innov17 LLC (US) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016014910-A1 | SULFONAMIDE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | INNOV17 LLC (US) | 2016-01-28 | — | — | WO | disclosed |
| WO-2016014918-A1 | BENZIMIDAZOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | INNOV 17 LLC (US) | 2016-01-28 | — | — | WO | disclosed |
| WO-2016014916-A1 | AZAINDOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF | INNOV17 LLC (US) | 2016-01-28 | — | — | WO | disclosed |